Skip to Content

Current Classification and Management Strategies in CIDP

Anders Svenningsson, MD, PhD, Professor of Neurology at Karolinska Institutet, discusses the evolving classification of CIDP and its clinical implications. He reviews diagnostic strategies, including neurophysiology and CSF analysis, and highlights how disease variants and antibody profiles guide treatment decisions—from IVIG and steroids to emerging options.

Anders Svenningsson

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top